Competition to market generic drugs is diminishing in 2018, in our view. We forecast that lower competitive activity will persist in 2019, allowing for improvement in recently depressed generic drug price trends and industry profit margins.
Download the full thematic research to learn more!
Looking for more of CFRA's recent research? Click here